Programmed use of extracorporeal photochemotherapy in the complex treatment of Devergey’s disease

Relevance. One of the promising areas of modern medicine is the method of efferent therapy, selectively affecting the mechanisms of the immune system and homeostasis. The lack of effectiveness of drugs, their side effects and the emerging pharmacoresistance in patients with Devergy disease, contribute to the search for new methods of treatment based on extracorporeal photochemical treatment of peripheral blood cells. Objective. To study the clinical and pathogenetic significance of the programmed use of extracorporeal photochemotherapy in the complex treatment of Devergey's disease. Material and methods. Using the method of extracorporeal photochemotherapy, a programmed treatment of a patient with Devergy disease was carried out for 12 months. Results. In an in vitro study with incubation of cell media, it was found that the extracorporeal photochemotherapy technique induces lymphocyte apoptosis with maximum levels on the third day after the procedure, which confirms the pathogenetic significance of this technique in the complex treatment of patients with Devergee's disease. Conclusions. The inclusion of programmed extracorporeal photochemotherapy in the complex therapy of a patient with Devergey's disease made it possible to stop a very high activity of the disease, reduce the dosage of acetritin preparations and achieve long-term remission (more than 12 months of observation).

extracorporeal photochemotherapy, apoptosis, Devergey's disease, T-lymphocytes, cellular immunity, immune response